Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip D Greenberg

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2011
Ralph M. Steinman: a man, a microscope, a cell, and so much morePhilip D Greenberg
Nature Protocols|March 29, 2014
Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cellsMatthias Wölfl, Philip D Greenberg
Trends in Immunology|November 12, 2013
Tolerance and exhaustion: defining mechanisms of T cell dysfunctionAndrea Schietinger, Philip D Greenberg
Annual Review of Cancer Biology|September 1, 2023
Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor-Based Cellular TherapyTijana Martinov, Philip D Greenberg
Science (New York, N.Y.)|July 13, 2004
Cancer immunotherapy: a treatment for the massesJoseph N Blattman, Philip D Greenberg
Cancer Cell|June 15, 2016
Pancreatic Cancer: Planning Ahead for Metastatic SpreadIngunn M Stromnes, Philip D Greenberg
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Selective delivery of augmented IL-2 receptor signals to responding CD8+ T cells increases the size of the acute antiviral response and of the resulting memory T cell poolLaurence E Cheng, Philip D Greenberg
Cancer Immunology Research|January 5, 2022
A New Year, A New InitiativeRobert D Schreiber, Philip D Greenberg
Cancer Immunology Research|January 3, 2023
Cancer Immunology Research: A Decade of Illumination and InnovationRobert D Schreiber, Philip D Greenberg
Nature Immunology|February 17, 2006
PD-1 blockade: rescue from a near-death experienceJoseph N Blattman, Philip D Greenberg
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2011
Ralph M. Steinman: a man, a microscope, a cell, and so much morePhilip D Greenberg
Nature Protocols|March 29, 2014
Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cellsMatthias Wölfl, Philip D Greenberg
Trends in Immunology|November 12, 2013
Tolerance and exhaustion: defining mechanisms of T cell dysfunctionAndrea Schietinger, Philip D Greenberg
Annual Review of Cancer Biology|September 1, 2023
Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor-Based Cellular TherapyTijana Martinov, Philip D Greenberg
Science (New York, N.Y.)|July 13, 2004
Cancer immunotherapy: a treatment for the massesJoseph N Blattman, Philip D Greenberg
Cancer Cell|June 15, 2016
Pancreatic Cancer: Planning Ahead for Metastatic SpreadIngunn M Stromnes, Philip D Greenberg
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Selective delivery of augmented IL-2 receptor signals to responding CD8+ T cells increases the size of the acute antiviral response and of the resulting memory T cell poolLaurence E Cheng, Philip D Greenberg
Cancer Immunology Research|January 5, 2022
A New Year, A New InitiativeRobert D Schreiber, Philip D Greenberg
Cancer Immunology Research|January 3, 2023
Cancer Immunology Research: A Decade of Illumination and InnovationRobert D Schreiber, Philip D Greenberg
Nature Immunology|February 17, 2006
PD-1 blockade: rescue from a near-death experienceJoseph N Blattman, Philip D Greenberg
Pageof 14